JY
PDSB icon

Jeff Yass’s PDS Biotechnology PDSB Stock Holding History

Jeff Yass’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-36,800
Closed -$141K – 12957
2024
Q3 		$141K Buy
36,800
+20,100
+120% +$67.1K ﹤0.01% 10801
2024
Q2 		$48.9K Sell
16,700
-131,100
-89% -$419K ﹤0.01% 11422
2024
Q1 		$585K Sell
147,800
-38,600
-21% -$199K ﹤0.01% 8129
2023
Q4 		$926K Buy
186,400
+27,400
+17% +$136K ﹤0.01% 7165
2023
Q3 		$803K Buy
159,000
+24,600
+18% +$135K ﹤0.01% 7140
2023
Q2 		$676K Buy
134,400
+83,900
+166% +$549K ﹤0.01% 7601
2023
Q1 		$311K Sell
50,500
-70,300
-58% -$575K ﹤0.01% 9651
2022
Q4 		$1.59M Buy
120,800
+58,100
+93% +$410K ﹤0.01% 5146
2022
Q3 		$186K Sell
62,700
-59,000
-48% -$250K ﹤0.01% 10947
2022
Q2 		$444K Buy
121,700
+63,900
+111% +$304K ﹤0.01% 8570
2022
Q1 		$358K Buy
57,800
+3,600
+7% +$22.4K ﹤0.01% 9833
2021
Q4 		$439K Sell
54,200
-66,800
-55% -$719K ﹤0.01% 9526
2021
Q3 		$1.8M Sell
121,000
-83,700
-41% -$1.04M ﹤0.01% 6066
2021
Q2 		$2.57M Buy
+204,700
New +$1.6M ﹤0.01% 5362

Other funds holding PDSB

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
MCM
Militia Capital Management Austin, Texas $3.37B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Jeff Yass's PDSB Position: Q2 2026 in Review

Jeff Yass increased its PDS Biotechnology (PDSB) stake by 65% in Q2 2026, buying an estimated $15.2K and bringing the position to 36,328 shares worth $32K. The position accounts for ﹤0.01% of the portfolio, ranked #12943.

Jeff Yass first reported a position in PDSB in Q4 2015 and has held it in 26 quarters since. The position peaked at $5M in Q3 2021. 52 funds tracked by Wall St. Rank hold PDSB as of Q2 2026.

  • Jeff Yass held 36,328 shares of PDS Biotechnology worth $32K as of Q2 2026.
  • Jeff Yass bought 14,276 PDS Biotechnology shares in Q2 2026, an estimated $15.2K.
  • PDS Biotechnology made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #12943 holding.
  • Jeff Yass first reported a position in PDS Biotechnology in Q4 2015 and has held it in 26 quarters since.
  • Jeff Yass's PDS Biotechnology position peaked at $5M in Q3 2021.
  • 52 funds tracked by Wall St. Rank held PDS Biotechnology as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.